Clin2
NCT04713670Possibly a fitRecruiting

Tested medicines to cure new H. pylori infection

H. Pylori Infection

Part of Digestive system, Infections clinical trials.

This trial compares different stomach-medicine combinations to eliminate a new (first-time) H. pylori infection. It may help find the most effective treatment approach for people who have never tried eradication therapy before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
1,200 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You have a new H. pylori infection (you have never been treated to clear it before).
  • You are over 20 years old.
  • You have not had the stomach surgery called total or subtotal gastrectomy.
  • You do not have serious long-term illness like end-stage kidney disease, liver cirrhosis, or cancer that can’t be cured.
  • You are not pregnant or breastfeeding.
  • You can safely take the study medicines and have no past serious allergy to them.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07344506Recruiting· Phase 4
Cure H. pylori: New combination therapy for stomach infection

This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.

Karachi
NCT07012785Not yet recruiting
Yeast plus antibiotic for new H. pylori infections

This trial tests whether taking a special yeast (Saccharomyces boulardii) together with an antibiotic (minocycline) clears a first-time H. pylori stomach infection. It may help reduce side effects and improve treatment success.

Nanjing, Jiangsu
NCT05332444Recruiting· Phase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori

This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.

Taipei
NCT07130253Not yet recruiting
New treatment for stubborn H. pylori infection

This trial tests a new combination of medicines to get rid of H. pylori bacteria in people whose previous treatments have not worked. It aims to find a more effective way to clear the infection.

Taipei
NCT06731023Not yet recruiting
14-day treatment for hard-to-cure H. pylori infection

This study tests a 14-day treatment plan for people whose H. pylori infection has not been cured by previous treatments. The plan is guided by lab tests to choose the best antibiotics, which may increase the chance of clearing the infection.

Jinan, Shandong
NCT06777732Not yet recruiting· Early Phase 1
Testing a new medicine for clearing H. pylori stomach infection

This study tests a new medicine called Keverprazan, which may help get rid of the H. pylori bacteria that causes stomach ulcers and other problems. If you have H. pylori and haven't been treated before, this trial could help you clear the infection with a new approach.

Hear when a new H. Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.